Estimating the protein activity of BCL-2, BCL-XL, and MCL-1 within the entire NCT/DKTK MASTER cohort (n = 1521) showed distinct differences between entities, with CRC showing one of the highest activities of BCL-XL (Fig. 1c). This evidence concerns the gene MCL1 and colorectal carcinoma.